Foundation Medicine Company Profile (NASDAQ:FMI)

About Foundation Medicine (NASDAQ:FMI)

Foundation Medicine logoFoundation Medicine, Inc. is a molecular information company. The Company sells products that are enabled by its molecular information platform to physicians and biopharmaceutical companies. It is engaged in the business of delivering molecular information about cancer to its customers. Its platform includes various methods and algorithms for analyzing specimens across various types of cancer. Its suite of clinical molecular information products includes FoundationOne, which is used for solid tumors; FoundationOne Heme, which is used for blood-based cancers or hematologic malignancies, including leukemia, lymphoma, myeloma, pediatric cancers and advanced sarcoma; FoundationACT (Assay for Circulating Tumor DNA), which is a blood-based (liquid biopsy) assay that evaluates circulating tumor deoxyribonucleic acid (ctDNA), and FoundationFocus CDxBRCA, which is a companion diagnostic assay to aid in identifying women with ovarian cancer for whom treatment with Rubraca (rucaparib).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: N/A
  • Symbol: NASDAQ:FMI
  • CUSIP: N/A
  • Web: www.foundationmedicine.com
Capitalization:
  • Market Cap: $1.4805 billion
  • Outstanding Shares: 36,021,000
Average Prices:
  • 50 Day Moving Avg: $41.30
  • 200 Day Moving Avg: $38.24
  • 52 Week Range: $17.10 - $47.35
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -10.65
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $119.58 million
  • Price / Sales: 12.38
  • Book Value: $2.49 per share
  • Price / Book: 16.51
Profitability:
  • EBITDA: ($140,790,000.00)
  • Net Margins: -131.79%
  • Return on Equity: -109.63%
  • Return on Assets: -81.74%
Debt:
  • Current Ratio: 2.17%
  • Quick Ratio: 1.99%
Misc:
  • Average Volume: 162,492 shs.
  • Beta: -0.13
  • Short Ratio: 18.92
 

Frequently Asked Questions for Foundation Medicine (NASDAQ:FMI)

What is Foundation Medicine's stock symbol?

Foundation Medicine trades on the NASDAQ under the ticker symbol "FMI."

How were Foundation Medicine's earnings last quarter?

Foundation Medicine, Inc. (NASDAQ:FMI) issued its quarterly earnings data on Tuesday, August, 1st. The company reported ($1.24) earnings per share for the quarter, missing the consensus estimate of ($1.08) by $0.16. The business earned $35 million during the quarter, compared to analyst estimates of $34.94 million. Foundation Medicine had a negative return on equity of 109.63% and a negative net margin of 131.79%. Foundation Medicine's revenue for the quarter was up 23.9% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.84) EPS. View Foundation Medicine's Earnings History.

When will Foundation Medicine make its next earnings announcement?

Foundation Medicine is scheduled to release their next quarterly earnings announcement on Tuesday, October, 31st 2017. View Earnings Estimates for Foundation Medicine.

Where is Foundation Medicine's stock going? Where will Foundation Medicine's stock price be in 2017?

4 analysts have issued 1-year price targets for Foundation Medicine's stock. Their predictions range from $31.00 to $39.00. On average, they expect Foundation Medicine's stock price to reach $35.00 in the next twelve months. View Analyst Ratings for Foundation Medicine.

Who are some of Foundation Medicine's key competitors?

Who are Foundation Medicine's key executives?

Foundation Medicine's management team includes the folowing people:

  • Michael J. Pellini M.D., Chairman of the Board
  • Steven J Kafka Ph.D., President, Chief Operating Officer
  • Troy Cox, Chief Executive Officer, Director
  • Jason Ryan, Chief Financial Officer, Principal Financial Officer, Principal Accounting officer
  • Robert Hesslein, Senior Vice President, General Counsel
  • Vincent Miller M.D., Chief Medical Officer
  • Alexis Borisy, Director
  • Michael R. Dougherty, Director
  • Evan Jones, Independent Director
  • Krishna Yeshwant, Independent Director

How do I buy Foundation Medicine stock?

Shares of Foundation Medicine can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Foundation Medicine's stock price today?

One share of Foundation Medicine stock can currently be purchased for approximately $41.10.


MarketBeat Community Rating for Foundation Medicine (NASDAQ FMI)
Community Ranking:  1.3 out of 5 (star)
Outperform Votes:  86 (Vote Outperform)
Underperform Votes:  240 (Vote Underperform)
Total Votes:  326
MarketBeat's community ratings are surveys of what our community members think about Foundation Medicine and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Foundation Medicine (NASDAQ:FMI) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $35.00 (14.84% downside)
Consensus Price Target History for Foundation Medicine (NASDAQ:FMI)
Price Target History for Foundation Medicine (NASDAQ:FMI)
Analysts' Ratings History for Foundation Medicine (NASDAQ:FMI)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/15/2017BTIG ResearchUpgradeNeutral -> Buy$39.00HighView Rating Details
4/3/2017William BlairReiterated RatingBuyLowView Rating Details
3/7/2017Janney Montgomery ScottUpgradeSell -> Neutral$31.00N/AView Rating Details
11/3/2016Benchmark Co.DowngradeBuy -> HoldN/AView Rating Details
8/3/2016J P Morgan Chase & CoReiterated RatingHold$25.00N/AView Rating Details
5/4/2016Leerink SwannReiterated RatingHoldN/AView Rating Details
2/26/2016Goldman Sachs Group, Inc. (The)Lower Price TargetNeutral$17.00 -> $15.00N/AView Rating Details
11/4/2015WedbushLower Price TargetNeutral$26.00 -> $19.00N/AView Rating Details
(Data available from 10/22/2015 forward)

Earnings

Earnings History for Foundation Medicine (NASDAQ:FMI)
Earnings by Quarter for Foundation Medicine (NASDAQ:FMI)
Earnings History by Quarter for Foundation Medicine (NASDAQ FMI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2017($1.06)N/AView Earnings Details
8/1/2017Q2 2017($1.08)($1.24)$34.94 million$35.00 millionViewListenView Earnings Details
5/9/2017Q1 2017($1.02)($1.31)$29.07 million$26.32 millionViewListenView Earnings Details
2/22/2017Q416($0.96)($1.02)$29.23 million$28.80 millionViewListenView Earnings Details
11/2/2016Q316($0.88)($0.90)$28.70 million$29.43 millionViewN/AView Earnings Details
8/2/2016Q216($0.79)($0.84)$26.72 million$28.24 millionViewN/AView Earnings Details
5/3/2016Q116($0.72)($0.50)$25.20 million$30.40 millionViewN/AView Earnings Details
2/23/2016Q415($0.67)($0.55)$25.76 million$26.10 millionViewListenView Earnings Details
11/3/2015Q315($0.56)($0.60)$24.04 million$25.40 millionViewListenView Earnings Details
7/29/2015Q215($0.56)($0.98)$24.44 million$22.50 millionViewListenView Earnings Details
5/11/2015Q115($0.53)($0.59)$21.00 million$19.30 millionViewListenView Earnings Details
2/24/2015Q314($0.53)($0.47)$18.05 million$18.70 millionViewListenView Earnings Details
11/5/2014Q3($0.49)($0.46)$15.60 million$16.40 millionViewN/AView Earnings Details
8/12/2014Q214($0.50)($0.49)$13.39 million$14.50 millionViewN/AView Earnings Details
5/7/2014Q114($0.48)($0.44)$11.33 million$11.45 millionViewN/AView Earnings Details
2/25/2014Q413($0.43)($0.48)$9.01 million$9.66 millionViewN/AView Earnings Details
11/6/2013($0.51)($3.51)$6.92 million$8.20 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Foundation Medicine (NASDAQ:FMI)
Current Year EPS Consensus Estimate: $-4.59 EPS
Next Year EPS Consensus Estimate: $-3.86 EPS

Dividends

Dividend History for Foundation Medicine (NASDAQ:FMI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Foundation Medicine (NASDAQ:FMI)
Insider Ownership Percentage: 2.70%
Institutional Ownership Percentage: 31.84%
Insider Trades by Quarter for Foundation Medicine (NASDAQ:FMI)
Institutional Ownership by Quarter for Foundation Medicine (NASDAQ:FMI)
Insider Trades by Quarter for Foundation Medicine (NASDAQ:FMI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/13/2017Steven J KafkaCOOSell3,361$44.62$149,967.82View SEC Filing  
10/12/2017Jason RyanCFOSell1,152$45.05$51,897.60View SEC Filing  
10/2/2017Jason RyanCFOSell3,154$38.80$122,375.20View SEC Filing  
10/2/2017Michael J PelliniDirectorSell4,349$38.80$168,741.20View SEC Filing  
10/2/2017Robert W HessleinSVPSell2,165$38.80$84,002.00View SEC Filing  
10/2/2017Steven J KafkaCOOSell3,201$38.80$124,198.80View SEC Filing  
10/2/2017Vincent A MillerInsiderSell2,944$38.80$114,227.20View SEC Filing  
8/9/2017David DalyInsiderSell46,872$39.50$1,851,444.00View SEC Filing  
8/9/2017Michael J PelliniDirectorSell30,000$39.52$1,185,600.00View SEC Filing  
8/8/2017Krishna YeshwantDirectorSell4,800$40.01$192,048.00View SEC Filing  
8/4/2017Krishna YeshwantDirectorSell18,072$36.85$665,953.20View SEC Filing  
7/14/2017Steven J KafkaCOOSell11,781$39.15$461,226.15View SEC Filing  
7/13/2017Jason RyanCFOSell5,084$39.77$202,190.68View SEC Filing  
7/6/2017David DalyInsiderSell6,316$38.84$245,313.44View SEC Filing  
7/6/2017Jason RyanCFOSell6,683$38.84$259,567.72View SEC Filing  
7/6/2017Michael J. PelliniDirectorSell15,856$38.84$615,847.04View SEC Filing  
7/6/2017Robert W. HessleinSVPSell5,070$38.84$196,918.80View SEC Filing  
7/6/2017Steven J KafkaCOOSell19,708$38.93$767,232.44View SEC Filing  
7/5/2017Steven J KafkaCOOSell12,310$38.98$479,843.80View SEC Filing  
6/2/2017Jason RyanCFOSell5,573$40.00$222,920.00View SEC Filing  
6/1/2017David DalyInsiderSell555$38.30$21,256.50View SEC Filing  
4/18/2017Jason RyanCFOSell503$34.55$17,378.65View SEC Filing  
4/18/2017Steven J KafkaCOOSell4,405$34.55$152,192.75View SEC Filing  
4/3/2017David DalyInsiderSell2,070$31.96$66,157.20View SEC Filing  
4/3/2017Michael J. PelliniDirectorSell1,700$31.96$54,332.00View SEC Filing  
4/3/2017Robert W. HessleinSVPSell1,233$31.96$39,406.68View SEC Filing  
4/3/2017Steven J. KafkaCOOSell2,157$31.96$68,937.72View SEC Filing  
3/16/2017Jason RyanCFOSell12,500$31.68$396,000.00View SEC Filing  
3/16/2017Robert W HessleinSVPSell6,231$31.67$197,335.77View SEC Filing  
3/8/2017Michael J PelliniDirectorSell40,000$34.30$1,372,000.00View SEC Filing  
2/8/2017Steven J KafkaCOOSell10,415$23.24$242,044.60View SEC Filing  
1/13/2017Jason RyanCFOSell1,777$19.00$33,763.00View SEC Filing  
1/4/2017David DalyInsiderSell5,097$17.91$91,287.27View SEC Filing  
1/4/2017Jason RyanCFOSell4,665$17.74$82,757.10View SEC Filing  
1/4/2017Michael J. PelliniCEOSell14,637$17.67$258,635.79View SEC Filing  
1/4/2017Robert W. HessleinSVPSell4,682$17.74$83,058.68View SEC Filing  
1/4/2017Steven J. KafkaCOOSell8,390$17.72$148,670.80View SEC Filing  
12/1/2016David DalyInsiderSell564$19.95$11,251.80View SEC Filing  
11/22/2016Steven J KafkaCOOSell6,273$23.01$144,341.73View SEC Filing  
10/20/2016Jason RyanCFOSell506$22.45$11,359.70View SEC Filing  
10/20/2016Steven J KafkaCOOSell4,427$23.00$101,821.00View SEC Filing  
10/4/2016David DalyInsiderSell2,045$23.65$48,364.25View SEC Filing  
10/4/2016Michael J. PelliniCEOSell2,629$23.65$62,175.85View SEC Filing  
10/4/2016Robert W. HessleinSVPSell1,220$23.65$28,853.00View SEC Filing  
10/4/2016Steven J. KafkaCOOSell2,135$23.62$50,428.70View SEC Filing  
9/20/2016Steven J KafkaCOOSell9,469$23.70$224,415.30View SEC Filing  
8/19/2016Jason RyanCFOSell13,863$23.92$331,602.96View SEC Filing  
7/5/2016David DalyInsiderSell5,008$17.76$88,942.08View SEC Filing  
7/5/2016Jason RyanCFOSell4,687$17.63$82,631.81View SEC Filing  
7/5/2016Michael J. PelliniCEOSell10,160$17.63$179,120.80View SEC Filing  
7/5/2016Robert W. HessleinSVPSell4,705$17.62$82,902.10View SEC Filing  
7/5/2016Steven J. KafkaCOOSell6,495$17.67$114,766.65View SEC Filing  
6/3/2016David DalyInsiderSell472$21.66$10,223.52View SEC Filing  
4/1/2016Steven J KafkaCOOSell124$18.08$2,241.92View SEC Filing  
4/1/2016Vincent A MillerInsiderSell356$18.08$6,436.48View SEC Filing  
12/1/2015David DalyInsiderSell2,559$16.78$42,940.02View SEC Filing  
11/13/2015Michael J PelliniCEOBuy9,100$16.43$149,513.00View SEC Filing  
6/15/2015Krishna YeshwantDirectorSell183,860$32.98$6,063,702.80View SEC Filing  
4/7/2015Alexis BorisyDirectorSell234,542$50.00$11,727,100.00View SEC Filing  
4/7/2015Roche Holdings IncInsiderBuy15,604,288$50.00$780,214,400.00View SEC Filing  
4/7/2015Rock Ventures Lp ThirdMajor ShareholderSell3,976,278$50.00$198,813,900.00View SEC Filing  
3/5/2015Michael J PelliniCEOSell153,300$47.24$7,241,892.00View SEC Filing  
1/15/2015Steven J KafkaCOOSell15,000$48.38$725,700.00View SEC Filing  
1/12/2015Michael J PelliniCEOSell22,500$51.07$1,149,075.00View SEC Filing  
1/12/2015Robert W HessleinSVPSell7,000$52.11$364,770.00View SEC Filing  
1/12/2015Steven J KafkaCOOSell8,000$51.83$414,640.00View SEC Filing  
1/12/2015Vincent A MillerInsiderSell2,000$53.03$106,060.00View SEC Filing  
1/8/2015Robert W HessleinSVPSell4,000$23.03$92,120.00View SEC Filing  
12/29/2014Michael J PelliniCEOSell12,500$23.91$298,875.00View SEC Filing  
11/17/2014Jason RyanSVPSell3,541$24.90$88,170.90View SEC Filing  
11/14/2014Michael J PelliniCEOSell12,500$24.91$311,375.00View SEC Filing  
10/27/2014Jason RyanSVPSell2,360$25.00$59,000.00View SEC Filing  
10/27/2014Steven J KafkaCOOSell10,000$25.31$253,100.00View SEC Filing  
9/15/2014Jason RyanSVPSell2,361$21.92$51,753.12View SEC Filing  
8/18/2014Michael J PelliniCEOSell12,500$25.29$316,125.00View SEC Filing  
7/22/2014Steven J KafkaCOOSell10,000$27.14$271,400.00View SEC Filing  
7/15/2014Jason RyanSVPSell3,541$27.22$96,386.02View SEC Filing  
7/15/2014Vincent A MillerInsiderSell15,000$27.25$408,750.00View SEC Filing  
7/8/2014Robert W HessleinSVPSell4,000$27.22$108,880.00View SEC Filing  
7/2/2014Michael J PelliniCEOSell15,000$27.42$411,300.00View SEC Filing  
6/26/2014Jason RyanSVPSell1,180$25.00$29,500.00View SEC Filing  
6/26/2014Steven J KafkaCOOSell5,000$25.19$125,950.00View SEC Filing  
6/19/2014Steven J KafkaCOOSell5,000$24.46$122,300.00View SEC Filing  
6/16/2014Jason RyanSVPSell2,361$22.61$53,382.21View SEC Filing  
6/13/2014Krishna YeshwantDirectorSell1,300,000$22.40$29,120,000.00View SEC Filing  
6/5/2014Jason RyanSVPSell10,000$24.06$240,600.00View SEC Filing  
6/5/2014Steven J KafkaCOOSell4,500$24.19$108,855.00View SEC Filing  
5/6/2014Vincent MillerInsiderSell3,000$30.00$90,000.00View SEC Filing  
4/16/2014Jason RyanSVPSell3,541$26.36$93,340.76View SEC Filing  
4/16/2014Vincent MillerInsiderSell30,000$26.86$805,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Foundation Medicine (NASDAQ:FMI)
Latest Headlines for Foundation Medicine (NASDAQ:FMI)
Source:
Loading headlines, please wait.

Social

Chart

Foundation Medicine (FMI) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.